TipRanks
Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP
US Market
ELTP
Elite Pharmaceuticals
RESEARCH TOOLSreports
Want to see ELTP full AI Analyst Report?

Elite Pharmaceuticals (ELTP) Ratios

379 Followers

Elite Pharmaceuticals Ratios

ELTP's free cash flow for Q1 2027 was $0.42. For the 2027 fiscal year, ELTP's free cash flow was decreased by $ and operating cash flow was $0.23. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Jun 25Jun 24Mar 23
Liquidity Ratios
Current Ratio
 3.76 6.45 4.88 3.07 2.75
Quick Ratio
 2.97 -1.22K 3.50 2.08 1.53
Cash Ratio
 1.28 1.71K 0.96 0.54 1.00
Solvency Ratio
 1.68 1.19 -0.05 0.83 369.58
Operating Cash Flow Ratio
 0.63 1.37K 0.63 -0.25 0.43
Short-Term Operating Cash Flow Coverage
 16.26 103.89K 1.76 -0.76 10.74
Net Current Asset Value
$ 79.64M$ 72.70M$ 14.87M$ 13.94M$ 9.57M
Leverage Ratios
Debt-to-Assets Ratio
 0.04 0.04 0.11 0.14 0.10
Debt-to-Equity Ratio
 0.05 0.06 0.20 0.20 0.13
Debt-to-Capital Ratio
 0.05 0.06 0.17 0.17 0.12
Long-Term Debt-to-Capital Ratio
 0.03 0.03 0.05 0.05 0.11
Financial Leverage Ratio
 1.33 1.40 1.80 1.45 1.41
Debt Service Coverage Ratio
 24.84 64.03 -0.28 4.54 302.38
Interest Coverage Ratio
 115.14 125.95 25.38 18.33 1.82K
Debt to Market Cap
 0.01 <0.01 0.02 0.05 0.13
Interest Debt Per Share
 <0.01 <0.01 0.01 0.01 <0.01
Net Debt to EBITDA
 -0.74 -573.16 -0.14 1.84 -0.61
Profitability Margins
Gross Profit Margin
43.21%49.36%47.70%46.55%48.58%
EBIT Margin
30.74%33.56%0.86%1.86%0.01%
EBITDA Margin
32.08%34.92%3.38%4.46%0.02%
Operating Profit Margin
25.38%33.56%23.32%19.05%5.93%
Pretax Profit Margin
46.16%38.16%-0.06%0.82%11.67%
Net Profit Margin
40.19%30.14%-5.13%35.51%12.91%
Continuous Operations Profit Margin
40.19%30.14%-5.13%35.51%0.01%
Net Income Per EBT
87.05%78.98%8275.14%4342.25%110.64%
EBT Per EBIT
181.88%113.72%-0.27%4.29%196.82%
Return on Assets (ROA)
40.57%32.45%-4.48%24.04%10783.21%
Return on Equity (ROE)
65.59%45.38%-8.06%34.92%15227.43%
Return on Capital Employed (ROCE)
32.77%41.32%23.18%15.28%6125.12%
Return on Invested Capital (ROIC)
28.22%32.33%21.87%14.27%6065.36%
Return on Tangible Assets
42.01%-0.96%-4.75%26.01%12762.06%
Earnings Yield
20.38%11.54%-0.93%12.94%15012.72%
Efficiency Ratios
Receivables Turnover
 2.80 2.49 2.88 2.91 11.04K
Payables Turnover
 14.32 12.45 14.86 11.15 7.18K
Inventory Turnover
 3.31 <0.01 2.71 2.34 1.84K
Fixed Asset Turnover
 10.59 0.01 5.96 3.88 3.27K
Asset Turnover
 1.01 1.08 0.87 0.68 835.17
Working Capital Turnover Ratio
 1.58 2.12 2.31 2.79 2.64K
Cash Conversion Cycle
 215.38 103.04K 237.14 248.59 0.18
Days of Sales Outstanding
 130.56 146.41 126.85 125.39 0.03
Days of Inventory Outstanding
 110.31 102.92K 134.85 155.93 0.20
Days of Payables Outstanding
 25.49 29.31 24.56 32.73 0.05
Operating Cycle
 240.87 103.07K 261.70 281.32 0.23
Cash Flow Ratios
Operating Cash Flow Per Share
 0.02 22.14 <0.01 >-0.01 <0.01
Free Cash Flow Per Share
 0.02 21.27 <0.01 >-0.01 >-0.01
CapEx Per Share
 <0.01 0.86 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.92 0.96 0.66 1.25 -0.72
Dividend Paid and CapEx Coverage Ratio
 12.56 25.66 2.95 -4.05 0.58
Capital Expenditure Coverage Ratio
 12.56 25.66 2.95 -4.05 0.58
Operating Cash Flow Coverage Ratio
 3.42 4.08K 0.68 -0.28 0.86
Operating Cash Flow to Sales Ratio
 0.14 159.52 0.09 -0.06 <0.01
Free Cash Flow Yield
6.30%5870.03%1.06%-2.63%-8.16%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 5.16 8.67 -108.75 7.73 <0.01
Price-to-Sales (P/S) Ratio
 1.97 2.61 5.53 2.74 <0.01
Price-to-Book (P/B) Ratio
 2.65 3.93 8.68 2.70 1.01
Price-to-Free Cash Flow (P/FCF) Ratio
 15.86 0.02 94.25 -37.97 -12.25
Price-to-Operating Cash Flow Ratio
 14.60 0.02 62.33 -47.34 8.80
Price-to-Earnings Growth (PEG) Ratio
 <0.01 >-0.01 0.90 -0.08 <0.01
Price-to-Fair Value
 2.65 3.93 8.68 2.70 1.01
Enterprise Value Multiple
 5.41 -565.68 163.34 63.41 3.96
Enterprise Value
 244.67M -29.40B 464.31M 159.99M 25.43M
EV to EBITDA
 5.41 -565.68 163.34 63.41 3.96
EV to Sales
 1.74 -197.51 5.52 2.83 <0.01
EV to Free Cash Flow
 13.96 -1.29 94.17 -39.11 -10.60
EV to Operating Cash Flow
 12.85 -1.24 62.28 -48.76 7.62
Tangible Book Value Per Share
 0.09 -4.37 0.04 0.05 0.02
Shareholders’ Equity Per Share
 0.10 0.09 0.05 0.06 0.03
Tax and Other Ratios
Effective Tax Rate
 0.13 0.21 -81.75 -42.42 -0.11
Revenue Per Share
 0.13 0.14 0.08 0.06 33.72
Net Income Per Share
 0.05 0.04 >-0.01 0.02 4.35
Tax Burden
 0.87 0.79 82.75 43.42 1.11
Interest Burden
 1.50 1.14 -0.07 0.44 781.76
Research & Development to Revenue
 0.04 38.58 0.09 0.12 0.18
SG&A to Revenue
 0.13 118.20 0.11 0.12 0.15
Stock-Based Compensation to Revenue
 1.25 1.19 <0.01 0.15 <0.01
Income Quality
 <0.01 0.53 -1.73 -0.16 0.94
Currency in USD